Education
About Us
Working with TipRanks
Follow Us
Aarti Drugs Limited (IN:AARTIDRUGS)
:AARTIDRUGS
Total Valuation
Aarti Drugs Limited has a market cap or net worth of ₹30.89B. The enterprise value is ₹36.62B.
Market Cap₹30.89B
Enterprise Value₹36.62B
Share Statistics
Aarti Drugs Limited has 91,270,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding91,270,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Aarti Drugs Limited’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 28.14%.
Return on Equity (ROE)0.12
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)28.14%
Return on Capital Employed (ROCE)0.42
Revenue Per Employee22.43M
Profits Per Employee1.58M
Employee Count1,064
Asset Turnover0.93
Inventory Turnover3.26
Valuation Ratios
The current PE Ratio of Aarti Drugs Limited is 23.2. Aarti Drugs Limited’s PEG ratio is -16.53.
PE Ratio23.2
PS Ratio1.32
PB Ratio2.30
Price to Fair Value2.30
Price to FCF46.64
Price to Operating Cash Flow20.31
PEG Ratio-16.53
Income Statement
In the last 12 months, Aarti Drugs Limited had revenue of 23.87B and earned 1.68B in profits. Earnings per share was 18.35.
Revenue23.87B
Gross Profit8.45B
Operating Income7.33B
Pretax Income2.12B
Net Income1.68B
EBITDA2.87B
Earnings Per Share (EPS)18.35
Cash Flow
In the last 12 months, operating cash flow was 1.52B and capital expenditures -943.10M, giving a free cash flow of 580.50M billion.
Operating Cash Flow1.52B
Free Cash Flow580.50M
Free Cash Flow per Share6.36
Dividends & Yields
Aarti Drugs Limited pays an annual dividend of ₹1, resulting in a dividend yield of 0.24%
Dividend Per Share₹1
Dividend Yield0.24%
Payout Ratio4.59%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.09
52-Week Price Change2.30%
50-Day Moving Average375.82
200-Day Moving Average447.49
Relative Strength Index (RSI)33.01
Average Volume (3m)11.99K
Important Dates
Aarti Drugs Limited upcoming earnings date is May 11, 2026, TBA (Confirmed).
Last Earnings DateFeb 3, 2026
Next Earnings DateMay 11, 2026
Ex-Dividend Date―
Financial Position
Aarti Drugs Limited as a current ratio of 1.60, with Debt / Equity ratio of 39.06%
Current Ratio1.60
Quick Ratio1.03
Debt to Market Cap0.19
Net Debt to EBITDA2.12
Interest Coverage Ratio20.43
Taxes
In the past 12 months, Aarti Drugs Limited has paid 436.80M in taxes.
Income Tax436.80M
Effective Tax Rate0.21
Enterprise Valuation
Aarti Drugs Limited EV to EBITDA ratio is 13.07, with an EV/FCF ratio of 55.65.
EV to Sales1.57
EV to EBITDA13.07
EV to Free Cash Flow55.65
EV to Operating Cash Flow15.34
Balance Sheet
Aarti Drugs Limited has ₹245.40M in cash and marketable securities with ₹5.73B in debt, giving a net cash position of -₹5.49B billion.
Cash & Marketable Securities₹245.40M
Total Debt₹5.73B
Net Cash-₹5.49B
Net Cash Per Share-₹60.15
Tangible Book Value Per Share₹148.65
Margins
Gross margin is 34.32%, with operating margin of 30.70%, and net profit margin of 7.04%.
Gross Margin34.32%
Operating Margin30.70%
Pretax Margin8.87%
Net Profit Margin7.04%
EBITDA Margin12.03%
EBIT Margin9.69%
Analyst Forecast
The average price target for Aarti Drugs Limited is ₹480.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target₹480.00
Price Target Upside18.58% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast4.08%
EPS Growth Forecast31.52%